Medicus Pharma Ltd. -29MDCXWPreferred / convertible
13F holders, Q1 2026 (March 31)6holders +1
1new positions
0sold out
$0.70avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Medicus Pharma Ltd. -29 (MDCXW) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($58K), Private Advisor Group, LLC ($27K) and Anson Funds Management LP ($19K).
- Company
- Medicus Pharma Ltd. -29
- CUSIP
- 58471K111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $820 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,465 shares bought, net +1,465 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Armistice Capital, LLC | — | No change | 60,600 | $58K |
| Private Advisor Group, LLC | — | No change | 49,000 | $27K |
| Anson Funds Management LP | — | No change | 42,400 | $19K |
| Empery Asset Management, LP | — | No change | 12,100 | $11K |
| Connective Capital Management, LLC | — | No change | 6,000 | $3K |
| UBS Group AG | — | New | 1,465 | $820 |
"% of holder's portfolio" is MDCXW's weight in each manager's 13F, not the share of Medicus Pharma Ltd. -29 the manager owns.